ATE375393T1 - Verfahren zur herstellung eines peptids mittels eines hilfspeptids - Google Patents

Verfahren zur herstellung eines peptids mittels eines hilfspeptids

Info

Publication number
ATE375393T1
ATE375393T1 AT99901926T AT99901926T ATE375393T1 AT E375393 T1 ATE375393 T1 AT E375393T1 AT 99901926 T AT99901926 T AT 99901926T AT 99901926 T AT99901926 T AT 99901926T AT E375393 T1 ATE375393 T1 AT E375393T1
Authority
AT
Austria
Prior art keywords
peptide
target
protein
producing
solubility
Prior art date
Application number
AT99901926T
Other languages
English (en)
Inventor
Kazuhiro Ohsuye
Masayuki Yabuta
Yuji Suzuki
Original Assignee
Asubio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asubio Pharma Co Ltd filed Critical Asubio Pharma Co Ltd
Application granted granted Critical
Publication of ATE375393T1 publication Critical patent/ATE375393T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99901926T 1998-01-30 1999-01-29 Verfahren zur herstellung eines peptids mittels eines hilfspeptids ATE375393T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3227298 1998-01-30

Publications (1)

Publication Number Publication Date
ATE375393T1 true ATE375393T1 (de) 2007-10-15

Family

ID=12354362

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99901926T ATE375393T1 (de) 1998-01-30 1999-01-29 Verfahren zur herstellung eines peptids mittels eines hilfspeptids

Country Status (12)

Country Link
EP (1) EP0978565B1 (de)
JP (1) JP4331270B2 (de)
KR (1) KR100627590B1 (de)
CN (1) CN1198937C (de)
AT (1) ATE375393T1 (de)
AU (1) AU765206B2 (de)
CA (1) CA2284847A1 (de)
DE (1) DE69937272T2 (de)
DK (1) DK0978565T3 (de)
IL (1) IL132030A (de)
NZ (1) NZ338004A (de)
WO (1) WO1999038984A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100445394C (zh) * 1999-03-04 2008-12-24 阿斯比奥制药株式会社 控制OmpT蛋白酶切割的方法
WO2001027310A1 (fr) * 1999-10-15 2001-04-19 Shionogi & Co., Ltd. Procede de production d'un precurseur d'adrenomeduline
KR100407792B1 (ko) * 2000-08-02 2003-12-01 한국생명공학연구원 인간 글루카곤 유사펩타이드를 융합파트너로 이용한재조합 단백질의 제조방법
GB0121591D0 (en) * 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
ES2615362T3 (es) 2001-07-27 2017-06-06 Glaxosmithkline Biologicals Sa Adhesinas de meningococos
US8129504B2 (en) 2001-08-30 2012-03-06 Biorexis Technology, Inc. Oral delivery of modified transferrin fusion proteins
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
EP1493747B1 (de) 2002-04-11 2012-12-19 Daiichi Sankyo Company, Limited Verfahren zur herstellung von modifiziertem peptid
AU2003243316A1 (en) 2002-05-24 2003-12-12 Nps Allelix Corp. Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
AU2003239863A1 (en) * 2002-05-24 2003-12-12 Restoragen Inc. Method for enzymatic production of glp-1 (7-36) amide peptides
AU2003239865A1 (en) 2002-05-24 2003-12-12 Restoragen Inc. Method for universal enzymatic production of bioactive peptides
WO2004037859A1 (ja) * 2002-10-11 2004-05-06 Sanwa Kagaku Kenkyusho Co., Ltd. Glp-1誘導体及びその経粘膜吸収型製剤
EP2351579B1 (de) 2002-10-11 2016-09-21 Novartis Vaccines and Diagnostics S.r.l. Poylpeptidimpfstoffe zum breiten Schutz gegen hypervirulente Meningo-kokken-Linien
WO2004078777A2 (en) * 2003-03-04 2004-09-16 Biorexis Pharmaceutical Corporation Dipeptidyl-peptidase protected proteins
US7829307B2 (en) 2003-11-21 2010-11-09 Nps Pharmaceuticals, Inc. Production of glucagon-like peptide 2
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
DK2038423T3 (da) 2006-06-21 2013-04-02 Biocon Ltd Fremgangsmåde til fremstilling af biologisk aktive polypeptider med insulinotropisk aktivitet
DK2046826T3 (da) 2006-07-24 2011-10-24 Biorexis Pharmaceutical Corp Exendin-fusionsproteiner
CN101578373A (zh) * 2006-09-06 2009-11-11 费斯生物制药公司 融合肽治疗组合物
CN105727261A (zh) 2008-06-27 2016-07-06 杜克大学 包含弹性蛋白样肽的治疗剂
CN104936610A (zh) * 2012-11-13 2015-09-23 益普生制药股份有限公司 Glp-1类似物的纯化方法
CN104592381A (zh) * 2013-10-31 2015-05-06 江苏万邦生化医药股份有限公司 一种利拉鲁肽中间体多肽的制备方法
RU2544959C1 (ru) * 2014-04-04 2015-03-20 Александр Владимирович Бубнов Способ получения пептидов
WO2016089782A1 (en) 2014-12-01 2016-06-09 Pfenex Inc. Fusion partners for peptide production
CN105669856A (zh) * 2016-02-13 2016-06-15 王大勇 一种基因重组长效人促肾上腺皮质激素及其制备方法
BR112020002804A2 (pt) 2017-08-24 2020-07-28 Novo Nordisk A/S composição farmacêutica líquida, e, kit
CN111378027B (zh) * 2018-12-29 2022-04-15 万新医药科技(苏州)有限公司 一种索玛鲁肽前体的制备方法
IL294521A (en) 2020-02-18 2022-09-01 Novo Nordisk As glp-1 compounds and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3531947B2 (ja) * 1991-08-19 2004-05-31 第一サントリーファーマ株式会社 ペプチドの製造方法
JP3995279B2 (ja) * 1994-09-07 2007-10-24 アスビオファーマ株式会社 蛋白の製造方法
CA2198966C (en) * 1996-03-04 2011-06-21 Yuji Suzuki Method for cleaving chimeric protein using processing enzyme

Also Published As

Publication number Publication date
DE69937272D1 (de) 2007-11-22
EP0978565B1 (de) 2007-10-10
CN1255945A (zh) 2000-06-07
WO1999038984A1 (fr) 1999-08-05
AU2185799A (en) 1999-08-16
IL132030A0 (en) 2001-03-19
DE69937272T2 (de) 2008-07-10
JP4331270B2 (ja) 2009-09-16
CA2284847A1 (en) 1999-08-05
DK0978565T3 (da) 2008-02-04
KR100627590B1 (ko) 2006-09-25
NZ338004A (en) 2001-08-31
CN1198937C (zh) 2005-04-27
EP0978565A4 (de) 2003-05-02
KR20010005859A (ko) 2001-01-15
AU765206B2 (en) 2003-09-11
IL132030A (en) 2009-06-15
EP0978565A1 (de) 2000-02-09

Similar Documents

Publication Publication Date Title
DE69937272D1 (de) Verfahren zur herstellung eines peptids mittels eines hilfspeptids
ATE353911T1 (de) Verfahren zur rekombinanten herstellung von antifusogenikpeptide
ATE372383T1 (de) Verfahren zur herstellung von l-aminosäuren
DE60030988D1 (de) Verfahren zur Herstellung Von L-Aminosäuren durch Erhöhung des zellulären NADPH
EP1350842A3 (de) Rekombinante terminale Deoxynukleotidyltransferase mit verbesserter Funktionalität
EA200100387A1 (ru) Роль секретазы в болезни альцгеймера
DK1942189T3 (da) Fremgangsmåde til fremstilling af sekreterede proteiner
EA200600408A1 (ru) Получение l-аскорбиновой кислоты в результате микробиологического процесса
ATE341640T1 (de) Verfahren zur herstellung von nicht-proteinogenen l-aminosäuren
DE60323215D1 (de) Neue carbonylreduktase, diese codierendes gen und verfahren zur produktion optisch-aktiver alkohole damit
ATE273269T1 (de) Verfahren zur abtrennung von einer basischen aminosäure aus fermentationsbrühen
DE60141633D1 (de) Neuartige glukose-6-phosphat dehydrogenase
TR200000086T2 (tr) Heparin üretimi için işlem.
DE3875953D1 (de) Verfahren zur herstellung von organischen chemischen verbindungen.
ATE386134T1 (de) Verfahren zur herstellung von glutathion
ATE488597T1 (de) Verfahren zur herstellung optisch aktiver aminosäuren unter verwendung eines ganzzellenkatalysators
ATE265541T1 (de) Verfahren zur fermentativen herstellung von nicht-proteinogenen l-aminosäuren
ATE439430T1 (de) Mutanten für die herstellung von d-aminosäuren
ATE319850T1 (de) Verfahren zur herstellung von aminosäuren
ATE501272T1 (de) Verfahren zur produktion von pflanzen mit verbesserter transpirationseffizienz sowie davon produzierte pflanzen
ATE274598T1 (de) Verfahren zur herstellung optisch aktiven n- benzyl-3-pyrrolidinols
AU3605701A (en) Process for the production of optically active beta-amino alcohols
ATE291094T1 (de) Verfahren zur herstellung von nukleosidderivaten
ATE202146T1 (de) Verbesserte enzymatische kupplungsreaktion von n- geschützte l-asparaginsäure und phenylalaninmethylester
RU2001117632A (ru) Способ получения l-аминокислот с использованием бактерий, принадлежащих к роду escherichia

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0978565

Country of ref document: EP